CompoAtlas

CREATINE MONOHYDRATE GUMMIES

Food supplement declared in France

CREATINE MONOHYDRATE GUMMIES (Jelly Pills) is a food supplement declared in France. Status: retiré du marché le 9 December 2025. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Jelly Pills
Food business operator placing the product on the market
Ropaco Distributors, S.L.
Status
Retiré du marché le 9 December 2025
Form
Gomme
Daily dose
2 gummies
Directions for use
Prendre 2 gummies par jour.
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Nourrissons (moins de 1 an), Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)

Declaration 346974, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Other active ingredients

NamePer day
Monohydrate de créatinenot declared

Additives

E160c, E903, E331, E330, E440

Other ingredients

Eau purifiée, sirop de glucose, sucre, Huile de coco

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ce complément alimentaire ne peut se substituer à une alimentation variée et équilibrée et à un mode de vie sain. Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des jeunes enfants.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : Jelly Pills

Enter to analyse, Shift+Enter for a new line